Quick Heal Technologies LimitedQ1 FY27 Results & Financial Update
Quick Heal Technologies Limited: Q1 FY27 consolidated results and company financials – revenue ₹45.00 Cr, PAT ₹-5.30 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Find an answer
Ask this result
Chart · Market context
Quick Heal Technologies price & chart
Quarter overview
Quarterly earnings analysis
During the first quarter of fiscal year 2027, Quick Heal Technologies reported consolidated revenue of INR 45 crore, reflecting contractions compared to both the preceding quarter and the corresponding period of the previous year. Management attributed the softer top-line performance primarily to ongoing market headwinds in the consumer segment alongside stricter partner credit control measures.
Profitability metrics remained in negative territory during the quarter, with EBITDA recorded at negative INR 17.6 crore and Profit After Tax (PAT) standing at negative INR 5.3 crore. The corresponding EBITDA margin was reported at negative 39.1 percent, reflecting the operational impact of lower revenue realization relative to ongoing corporate expenditure.
Despite consumer segment headwinds, the company experienced encouraging traction within its enterprise and government verticals. Leadership highlighted strategic multi-year order wins across high-priority sectors such as defense, banking, financial services, and IT services, reinforcing confidence in the long-term enterprise growth agenda.
Operationally, the organization focused on sharpening its go-to-market execution, enhancing organizational agility, and advancing its cybersecurity portfolio around AI-driven solutions, data privacy compliance, and advanced threat intelligence technologies.
01 · Business model
What does Quick Heal Technologies do?
Quick Heal Technologies Limited is a leading global provider of end-to-end cybersecurity solutions operating across B2C, B2B, and B2G segments. Incorporated in 1995 with its registered office in Pune, the company develops AI-powered and patented technologies that protect endpoints, networks, data, mobility, and cloud environments.
The company goes to market primarily through two major brands: 'Quick Heal' catering to consumer security needs, and 'Seqrite' serving enterprise and government requirements. Its portfolio encompasses antivirus software, fraud prevention tools, extended detection and response (XDR) systems, and specialized threat intelligence offerings.
Quick Heal's economic model relies heavily on channel partner networks, retail sales distributors, and direct enterprise contracts. The business balances ongoing investments in research and development with disciplined operational management and credit control across its distribution channels.
02 · Financial snapshot
Current quarter vs the two useful baselines
| Metric | Q1 FY27 | Year-ago | Previous quarter |
|---|---|---|---|
| Revenue from operations | ₹45.00 Cr | ₹57.20 Cr | ₹48.70 Cr |
| EBITDA | ₹-17.60 Cr | ₹-9.70 Cr | ₹-29.30 Cr |
| Profit after tax | ₹-5.30 Cr | ₹-5.50 Cr | ₹-19.90 Cr |
| EBITDA margin | -39.10% | -17.00% | -60.20% |
Financial interpretation
What the reported numbers mean
Profit after tax represented -11.8% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Revenue performance was supported by wins across high-priority sectors including defense, BFSI, and IT services.
The retail consumer vertical continued to face market headwinds, compounded by management's focused partner credit control initiatives.
What drove margins
Lower revenue realization on a sequential and year-on-year basis adversely impacted operating leverage, resulting in an EBITDA margin of negative 39.1 percent.
The company maintained ongoing investments in AI-driven cybersecurity capabilities, enterprise expansion, and product innovation despite near-term top-line pressures.
04 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
Seqrite secured a significant Extended Detection and Response (XDR) customer in the banking technology sector and an order for threat intelligence offerings from a major IT services firm.
The company was awarded a multi-year order to secure 1.5 lakh devices for the defense sector.
05 · Strategy & new businesses
How the company is trying to change its growth mix
Joined forces with JISA Softech to strengthen enterprise Digital Personal Data Protection (DPDP) compliance through integrated privacy technology.
Secured a new patent for advanced Network Access Control (NAC) technology to bolster enterprise network security offerings.
06 · Reported developments
What changed operationally
Appointed Harish Kumar G S as the Chief Executive Officer to lead strategic growth, business transformation, and expansion.
Seqrite Labs uncovered 'Operation XENOFISCAL', exposing a Pakistan-linked SideCopy Group deploying persistent XenoRAT against Afghanistan's Ministry of Finance.
07 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Management emphasized a focused collections strategy and prudent financial management to strengthen business fundamentals amidst market headwinds.
08 · Beyond the numbers
What changed beyond the numbers
New CEO Appointment
Harish Kumar G S assumed office as Chief Executive Officer, bringing over three decades of technology sector experience.
Threat Intelligence Discovery
Seqrite Labs uncovered the Operation XENOFISCAL cyber espionage campaign targeting international government infrastructure.
09 · Key Q&A
The quarter, answered directly
What does Quick Heal Technologies do?
Quick Heal Technologies Limited is a leading global provider of end-to-end cybersecurity solutions operating across B2C, B2B, and B2G segments. Incorporated in 1995 with its registered office in Pune, the company develops AI-powered and patented technologies that protect endpoints, networks, data, mobility, and cloud environments.
What is the clearest takeaway from Q1 FY27?
During the first quarter of fiscal year 2027, Quick Heal Technologies reported consolidated revenue of INR 45 crore, reflecting contractions compared to both the preceding quarter and the corresponding period of the previous year. Management attributed the softer top-line performance primarily to ongoing market headwinds in the consumer segment alongside stricter partner credit control measures.
What drove revenue or demand?
Revenue performance was supported by wins across high-priority sectors including defense, BFSI, and IT services.
What mattered most for margins or profitability?
Lower revenue realization on a sequential and year-on-year basis adversely impacted operating leverage, resulting in an EBITDA margin of negative 39.1 percent.
What changed operationally beyond the headline numbers?
Joined forces with JISA Softech to strengthen enterprise Digital Personal Data Protection (DPDP) compliance through integrated privacy technology.
What should the next disclosure help confirm?
Monitor subsequent quarters for stabilization and recovery in the retail consumer cybersecurity vertical.
10 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
11 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Consumer Demand Recovery: Monitor subsequent quarters for stabilization and recovery in the retail consumer cybersecurity vertical.
- 02
Enterprise Execution: Track continued traction and deployment progress across large defense, BFSI, and IT services enterprise contracts.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.
